SELECTION OF OPTIMAL APPROACHES TO PREVENTION OF NON-COMMUNICABLE DISEASES IN INTERNATIONAL PARTNERSHIP CIRCUMSTANCES
https://doi.org/10.15829/1728-8800-2018-1-4-9
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
The growth of social and economical burden of non-communicable diseases (NCD) in all countries around the globe stimulated the national and international institutions for development of political and strategic documents, commitments acception for prevention and control over these diseases. Such commitments, accepted by the countries, are discussed on international meetings of the World Health Organization, the United Nations, the economics of Asia-Pacific collaboration, Northern Dimension countries in the areas of healthcare and social wellbeing. In parallel with these, the professional national and international guidelines are being developed, representing effective populational and individual actions for NCD prevention. Such recommendations are in use in collaboration within projects and programming for economically proven and most efficient actions with further implementation at national levels. Selecting such actions, it is suggested to consider the NCD situation in an exact country, political and economical conditions, materials and technical base, human resources. Special attention is to be paid on selection of target groups for interventions, monitoring standards development and evaluation of efficacy of the joint projects. Main condition for monitoring of NCD situation, their risk factors and assessment of the efficacy programs is an accessible national and global databases that include various parameters of health, that are standardized with the global, regional and national.
About the Authors
G. Ya. Maslennikova
National Research Center for Preventive Medicine of the Ministry of Health
Russian Federation
Russian Federation
Moscow
R. G. Oganov
National Research Center for Preventive Medicine of the Ministry of Health
Russian Federation
Russian Federation
Moscow
References
1. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. ISBN 97892 4 1506236 (NLM classification: WT 500). Resolution WHA66.10 www.who.int/entity/nmh/events/ncd_task_force/en.
2. Sustainable Development Goals. New York: United Nations; 2015. Available from: https://sustainabledevelopment.un.org/?menu=1300 [cited 2015 Oct 2].
3. The Terms of Reference for the WHO GCM/NCD http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_14Add1-en.pdf.
4. United Nations Interagency Task Force on the Prevention and Control of NCDs are invited as participants of the WHO GCM/NCD http://apps.who.int/gb/ebwha/pdf_files/EB134/B134_14Add1-en.pdf United Nations General Assembly resolution 66/2 http://www.who.int/nmh/events/un_ncd_summit2011/political_declaration_en.pdf).
5. World health statistics 2017: monitoring health for the SDGs, Sustainable Development Goals. Geneva: World Health Organization; 2017. License: CC BY-NCSA 3.0 IGO. ISBN 978-92-4-156548-6, 116p.
6. Maslennikova GYa, Oganov RG, Boytsov SA, et al. Non-communicable diseases in Asia-Pacific Economic Cooperation member economies: opportunities for achieving the sustainable development goals by 2030. Preventive Medicine Journal 2016; 19 (5): 4-9. (in Russ.) Maslennikova G.Ya., Oganov R.G., Boitsov S.A. i dr. Neinfektsionnye zabolevaniya v ekonomikakh aziatsko-tikhookeanskogo ekonomicheskogo sotrudnichestva: vozmozhnosti dlya dostizheniya tselei ustoichivogo razvitiya k 2030g. Profilakticheskaya meditsina 2016; 19 (5): 4-9. https://doi.org/10.17116/profmed20161954-9.
7. Maslennikova GYa, Oganov RG. Cardiovascular and other non-communicable diseases in the countries of the Northern Dimension Partnership in Public Health and Social Well-being: priorities and better prevention approaches. Cardiovascular Therapy and Prevention 2017; 16 (5): 4-10. (in Russ.) Maslennikova G.Ya., Oganov R. G. Serdechno-sosudistye i drugie neinfektsionnye zabolevaniya v stranakh, vkhodyashchikh v Partnerstvo Severnoe Izmerenie v oblasti Zdravookhraneniya i Sotsial'nogo Blagopoluchiya: vybor prioritetov i luchshikh metodov ikh profilaktiki. Kardiovaskulyarnaya terapiya i profilaktika 2017; 16 (5): 4-10. https://doi.org/10.15829/1728-8800-2017-5-4-10.
8. Global Health Estimates 2015: Deaths by cause, age, sex, bu country and by region, 2000-2015. Geneva: World Health Organization; 2016 (http://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html,accessed 22 March 2017).
9. The Moscow Declaration of the First global ministerial conference on healthy lifestyles and noncommunicable diseases (NCDs) control in 2011. Moscow, 28-29 April 2011. (in Russ.) Moskovskaya Deklaratsiya Pervoi Global'noi Ministerskoi konferentsii po zdorovomu obrazu zhizni i neinfektsionnym zabolevaniyam. Moskva, 28-29 aprelya 2011. http://www.who.int/nmh/events/moscow_ncds_2011/conference_documents/en.
10. Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. New York: United Nations General Assembly; 2011. Document A/66/L.1. http://www.un.org/en/ga/ncdmeeting2011.
11. Oganov RG, Britov AN, Lukomskiy PE. On the prevention of cardiovascular diseases and modern approaches to mass prophylaxis of hypertension. Cardiology 1984; 24 (9): 8-10. (in Russ.) Oganov R.G., Britov A.N., Lukomskii P.E. O preduprezhdenii serdechno-sosudistykh zabolevanii i sovremennye podkhody k massovoi profilaktike arterial'noi gipertonii. Kardiologiya 1984; 24 (9): 8-10.
12. Britov AN, Sapozhnikov II, Makarova TG, et al. Medical efficacy of a cooperative prevention program of arterial hypertension. Cor et Vasa 1988; 30 (2): 97.
13. Alexandrov AA, Maslennikova GY, Kulikov SM, et al. Primary Prevention of cardiovascular disease: 3-year intervention results in boys of 12 years of age. Preventive Medicine 1992; 21 (1): 53-62.
14. Maslennikova GY, Morosova ME, Salman NV, et al. Asthma education programme in Russia: educating patients. Patient Education and Counseling 1998; 33 (2): 113-27.
15. Kalinina AM, Chazova LV. The effect of multifactorial prevention of cardiovascular diseases on the life expectancy (10 years of observation) Therapeutic archive 1998; 70 (1): 8-12. (in Russ.) Kalinina A.M., Chazova L.V. Vliyanie mnogofaktornoi profilaktiki serdechno-sosudistykh zabolevanii na prognoz zhizni (10-letnee nablyudenie). Terapevticheskii arkhiv 1998; 70 (1): 8-12.
16. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales, 1981-2000. Circulation 2004; 109: 1101-7.
17. Ford ES, Ajani UA, Croft JB, et al. Expanding the Decrease in the U.S. Deaths from Coronary Dissease, 1980-2000. The New Engl J Med 2007; 256 (23): 2388-98.
18. Capewell S, Ford ES, Croft JB, et al. Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America. Bull World Health Organ 2010; 88: 120-30. https://doi.org/10.2471/BLT.08.057885.
19. Framework on Community Based Intervention to Control NCD Risk Factors. APEC Health Working Group 2014.APEC#214-NT-03.1 ISBN: 978-981-09-1647-3.
20. European Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal (2016). https://doi.org/10.1093/eurhearti/ehw 106.
21. Workshop Report Strategies to Address Non-communicable Diseases through Science, Technology and Innovation: Nutrigenomics Approach (Philippines, 15-16 June 2016) APEC Policy Partnership on Science, Technology and Innovation. APEC Secretariat, January, 2017. APEC#217-PP-04.2.
22. Draft of the National clinical recommendations “Cardiovascular prevention 2017.” Moscow, 2017. S. 288. (in Rus.) Proekt Natsional'nykh klinicheskikh rekomendatsii “Kardiovaskulyarnaya profilaktika 2017g.” Moskva, 2017. 288 c. http://www.scardio.ru/content/Guidelines/project/Proekt_Kardiovascular_prof_2017.pdf.
23. Oganov RG, Maslennikova GYa. Individual prevention of cardiovascular diseases. The position of European cardiolody societies. Cardiovascular Therapy and Prevention 2017; 16 (1): 4-7. (in Russ.) Oganov R.G., Maslennikova G.Ya. Individual'naya profilaktika serdechno-sosudistykh zabolevanii. Pozitsiya evropeiskikh kardiologicheskikh obshchestv. Kardiovaskulyarnaya terapiya i profilaktika 2017; 16 (1): 4-7. https://doi.org/10.15829/1728-8800-2017-1-4-7.
24. Oganov RG, Maslennikova GYa. Population strategy for cardiovascular disease prevention: The stand of the European Sicieties of Cardiology. The Russian Journal of Preventive Medicine 2017; 20 (3): 4-7. (in Russ.) Oganov R.G., Maslennikova G.Ya. Populyatsionnaya strategiya profilaktiki serdechno-sosudistykh zabolevanii. Pozitsiya evropeiskikh kardiologicheskikh obshchestv. Profilakticheskaya meditsina 2017; 20(3): 4-7. https://doi.org/10.171116/profmed20172034-6.
25. The Draft of the Strategy “Formation of healthy lifestyle, prevention and control of NCDS by 2025” by 31.12.2015, No. 683. (in Russ.) Proekt Strategii “Formirovanie zdorovogo obraza zhizni, profilaktiki i kontrolya NIZ do 2025 goda” ot 31.12.2015, № 683.http://doc.knigi-x.ru/22raznoe/179966-1-proekt-mezhvedomstvennaya-strategiya-formirovaniya-zdorovogo-obraza-zhizninaseleniya-profilaktiki-kontrolya-neinfekcion.php
Review
For citations:
Maslennikova G.Ya., Oganov R.G. SELECTION OF OPTIMAL APPROACHES TO PREVENTION OF NON-COMMUNICABLE DISEASES IN INTERNATIONAL PARTNERSHIP CIRCUMSTANCES. Cardiovascular Therapy and Prevention. 2018;17(1):4-9. (In Russ.) https://doi.org/10.15829/1728-8800-2018-1-4-9
Views:
1087
ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)
ISSN 2619-0125 (Online)
Email this article 
